Carol Pena

Title: Carol Pena: Innovator in Cancer Treatment

Introduction

Carol Pena is a notable inventor based in Basking Ridge, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. Her work has led to the creation of a patent that showcases her expertise and dedication to improving patient outcomes.

Latest Patents

Carol Pena holds a patent for "Substituted 2,3-dihydroimidazo[1,2-C]quinazoline-containing combinations." This invention relates to combinations of specific compounds that can be used in the preparation of a medicament for the treatment or prophylaxis of cancer. The patent outlines various components, including 2,3-dihydroimidazo[1,2-c]quinazoline compounds and substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]-triazin-4-amine compounds. The invention also discusses methods for predicting patient sensitivity to treatment based on biomarkers, which is crucial for personalized medicine.

Career Highlights

Throughout her career, Carol has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer Healthcare Pharmaceuticals. Her experience in these organizations has allowed her to collaborate with leading experts and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of her notable coworkers include Isabelle Genvresse and Ningshu Liu. Their collaborative efforts have further advanced the research and development of innovative cancer therapies.

Conclusion

Carol Pena's contributions to the field of cancer treatment through her patent and collaborations highlight her role as a significant innovator. Her work continues to impact the pharmaceutical industry and improve the lives of patients facing cancer.